Cadence Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-7,443
Closed -$908K 364
2020
Q2
$908K Buy
7,443
+2,870
+63% +$350K 0.13% 235
2020
Q1
$396K Buy
+4,573
New +$396K 0.07% 343